BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 30742586)

  • 21. Pathways of cellular proteostasis in aging and disease.
    Klaips CL; Jayaraj GG; Hartl FU
    J Cell Biol; 2018 Jan; 217(1):51-63. PubMed ID: 29127110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aggregopathy in neurodegenerative diseases: mechanisms and therapeutic implication.
    Dohm CP; Kermer P; Bähr M
    Neurodegener Dis; 2008; 5(6):321-38. PubMed ID: 18309232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers.
    Ugalde CL; Finkelstein DI; Lawson VA; Hill AF
    J Neurochem; 2016 Oct; 139(2):162-180. PubMed ID: 27529376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteostasis Disturbances and Inflammation in Neurodegenerative Diseases.
    Sonninen TM; Goldsteins G; Laham-Karam N; Koistinaho J; Lehtonen Š
    Cells; 2020 Sep; 9(10):. PubMed ID: 32998318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Defective protein folding and aggregation as the basis of neurodegenerative diseases: the darker aspect of proteins.
    Naeem A; Fazili NA
    Cell Biochem Biophys; 2011 Nov; 61(2):237-50. PubMed ID: 21573992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein Misfolding Diseases and Therapeutic Approaches.
    Yadav K; Yadav A; Vashistha P; Pandey VP; Dwivedi UN
    Curr Protein Pept Sci; 2019; 20(12):1226-1245. PubMed ID: 31187709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A quantitative model of human neurodegenerative diseases involving protein aggregation.
    Kepp KP
    Neurobiol Aging; 2019 Aug; 80():46-55. PubMed ID: 31102901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autophagy Activator Drugs: A New Opportunity in Neuroprotection from Misfolded Protein Toxicity.
    Thellung S; Corsaro A; Nizzari M; Barbieri F; Florio T
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30791416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Collective roles of molecular chaperones in protein degradation pathways associated with neurodegenerative diseases.
    Luo GR; Le WD
    Curr Pharm Biotechnol; 2010 Feb; 11(2):180-7. PubMed ID: 20166963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A role of small heat shock protein B8 (HspB8) in the autophagic removal of misfolded proteins responsible for neurodegenerative diseases.
    Crippa V; Carra S; Rusmini P; Sau D; Bolzoni E; Bendotti C; De Biasi S; Poletti A
    Autophagy; 2010 Oct; 6(7):958-60. PubMed ID: 20699640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein clearance strategies for disease intervention.
    Hommen F; Bilican S; Vilchez D
    J Neural Transm (Vienna); 2022 Feb; 129(2):141-172. PubMed ID: 34689261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence Linking Protein Misfolding to Quality Control in Progressive Neurodegenerative Diseases.
    Kabir MT; Uddin MS; Abdeen A; Ashraf GM; Perveen A; Hafeez A; Bin-Jumah MN; Abdel-Daim MM
    Curr Top Med Chem; 2020; 20(23):2025-2043. PubMed ID: 32552649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ubiquitin-dependent and independent roles of SUMO in proteostasis.
    Liebelt F; Vertegaal AC
    Am J Physiol Cell Physiol; 2016 Aug; 311(2):C284-96. PubMed ID: 27335169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential roles of natural products in the targeting of proteinopathic neurodegenerative diseases.
    Dash R; Jahan I; Ali MC; Mitra S; Munni YA; Timalsina B; Hannan MA; Moon IS
    Neurochem Int; 2021 May; 145():105011. PubMed ID: 33711400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A review on protein misfolding, aggregation and strategies to prevent related ailments.
    Shamsi TN; Athar T; Parveen R; Fatima S
    Int J Biol Macromol; 2017 Dec; 105(Pt 1):993-1000. PubMed ID: 28743576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aptamer and its applications in neurodegenerative diseases.
    Qu J; Yu S; Zheng Y; Zheng Y; Yang H; Zhang J
    Cell Mol Life Sci; 2017 Feb; 74(4):683-695. PubMed ID: 27563707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurodegenerative diseases linked to misfolded proteins and their therapeutic approaches: A review.
    Khanam H; Ali A; Asif M; Shamsuzzaman
    Eur J Med Chem; 2016 Nov; 124():1121-1141. PubMed ID: 27597727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heat shock proteins in neurodegenerative diseases: pathogenic roles and therapeutic implications.
    Adachi H; Katsuno M; Waza M; Minamiyama M; Tanaka F; Sobue G
    Int J Hyperthermia; 2009 Dec; 25(8):647-54. PubMed ID: 20021225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advances in Proteasome Enhancement by Small Molecules.
    George DE; Tepe JJ
    Biomolecules; 2021 Nov; 11(12):. PubMed ID: 34944433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LRSAM1 E3 ubiquitin ligase: molecular neurobiological perspectives linked with brain diseases.
    Mishra R; Upadhyay A; Prajapati VK; Dhiman R; Poluri KM; Jana NR; Mishra A
    Cell Mol Life Sci; 2019 Jun; 76(11):2093-2110. PubMed ID: 30826859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.